• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

67-kD层粘连蛋白受体在乳腺癌进展中的表达谱

The spectrum of 67-kD laminin receptor expression in breast carcinoma progression.

作者信息

Viacava P, Naccarato A G, Collecchi P, Ménard S, Castronovo V, Bevilacqua G

机构信息

Institute of Pathology, University of Pisa, Italy.

出版信息

J Pathol. 1997 May;182(1):36-44. doi: 10.1002/(SICI)1096-9896(199705)182:1<36::AID-PATH802>3.0.CO;2-W.

DOI:10.1002/(SICI)1096-9896(199705)182:1<36::AID-PATH802>3.0.CO;2-W
PMID:9227340
Abstract

Laminin is a glycoprotein of the basement membrane (BM), involved in a variety of normal and pathological cellular events including tumour invasion and metastasis. Cells bind laminin through different types of receptor. The 67-kD laminin receptor (67LR) is a cell-surface protein which binds laminin with high affinity. 67LR expression has been shown to increase in neoplastic cells, compared with normal tissues, and 67LR seems to play an important role during the first steps of neoplastic progression. In this study, 67LR expression was analysed during the morphological phases of breast cancer progression from normal tissue to invasive carcinoma. A total of 506 formalin-fixed, paraffin-embedded normal breast structures and lesions were stained by immunohistochemistry usign the MLuC5 monoclonal antibody, which is specific for 67LR. The results show that in normal breast and in any kind of breast lesion, myoepithelial and endothelial cells express 67LR. While 67LR is not seen in the epithelium of normal breast, cysts, adenosis, and benign tumours, it is expressed in the epithelial cells of several hyperplasias and carcinomas in situ, both ductal and lobular, as well as in all invasive carcinomas. The 67LR-positive cell subpopulation expands from hyperplastic lesions to invasive carcinoma, suggesting that 67LR could be related to the induction and progression of breast cancer.

摘要

层粘连蛋白是基底膜(BM)的一种糖蛋白,参与包括肿瘤侵袭和转移在内的多种正常和病理细胞事件。细胞通过不同类型的受体与层粘连蛋白结合。67-kD层粘连蛋白受体(67LR)是一种细胞表面蛋白,它以高亲和力结合层粘连蛋白。与正常组织相比,肿瘤细胞中67LR的表达已被证明会增加,并且67LR似乎在肿瘤进展的最初阶段发挥重要作用。在本研究中,分析了乳腺癌从正常组织进展到浸润性癌的形态学阶段中67LR的表达情况。使用对67LR具有特异性的MLuC5单克隆抗体,通过免疫组织化学对总共506个福尔马林固定、石蜡包埋的正常乳腺结构和病变进行染色。结果表明,在正常乳腺以及任何类型的乳腺病变中,肌上皮细胞和内皮细胞表达67LR。虽然在正常乳腺、囊肿、腺病和良性肿瘤的上皮中未见67LR,但在一些导管和小叶的增生以及原位癌的上皮细胞中表达,以及在所有浸润性癌中均有表达。67LR阳性细胞亚群从增生性病变扩展到浸润性癌,表明67LR可能与乳腺癌的诱导和进展有关。

相似文献

1
The spectrum of 67-kD laminin receptor expression in breast carcinoma progression.67-kD层粘连蛋白受体在乳腺癌进展中的表达谱
J Pathol. 1997 May;182(1):36-44. doi: 10.1002/(SICI)1096-9896(199705)182:1<36::AID-PATH802>3.0.CO;2-W.
2
Overexpression of the 67-kD laminin receptor correlates with tumour progression in human colorectal carcinoma.67-kD层粘连蛋白受体的过表达与人类结直肠癌的肿瘤进展相关。
J Pathol. 1996 Aug;179(4):376-80. doi: 10.1002/(SICI)1096-9896(199608)179:4<376::AID-PATH591>3.0.CO;2-V.
3
67-kDa laminin receptor in human laryngeal squamous cell carcinoma.人喉鳞状细胞癌中的67-kDa层粘连蛋白受体
Laryngoscope. 2006 Jan;116(1):28-32. doi: 10.1097/01.mlg.0000184505.05662.b9.
4
Angiogenesis and VEGF expression in pre-invasive lesions of the human breast.人乳腺浸润前病变中的血管生成与血管内皮生长因子表达
J Pathol. 2004 Oct;204(2):140-6. doi: 10.1002/path.1626.
5
Different proliferative patterns characterize different preinvasive breast lesions.不同的增殖模式是不同的乳腺原位病变的特征。
J Pathol. 1999 Jul;188(3):245-51. doi: 10.1002/(SICI)1096-9896(199907)188:3<245::AID-PATH353>3.0.CO;2-6.
6
The 67 kDa laminin receptor increases tumor aggressiveness by remodeling laminin-1.67 kDa层粘连蛋白受体通过重塑层粘连蛋白-1增加肿瘤侵袭性。
Endocr Relat Cancer. 2005 Jun;12(2):393-406. doi: 10.1677/erc.1.00870.
7
A comparison of the patterns of laminin expression in fibroadenoma, fibrocystic diseases, pre-invasive and invasive ductal breast carcinoma.纤维腺瘤、纤维囊性疾病、乳腺导管原位癌及浸润性导管癌中层粘连蛋白表达模式的比较。
Pathology. 2001 Aug;33(3):303-6.
8
Loss of types XV and XIX collagen precedes basement membrane invasion in ductal carcinoma of the female breast.在女性乳腺癌导管癌中,XV型和XIX型胶原蛋白的缺失先于基底膜浸润。
J Pathol. 2003 Mar;199(3):298-308. doi: 10.1002/path.1303.
9
The expression of Fhit protein is related inversely to disease progression in patients with breast carcinoma.Fhit蛋白的表达与乳腺癌患者的疾病进展呈负相关。
Cancer. 2000 Mar 15;88(6):1378-83.
10
Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer.在一种可靠的人类乳腺癌小鼠模型中,转移肿瘤抗原家族蛋白在乳腺癌进展和转移过程中的作用
Clin Cancer Res. 2006 Mar 1;12(5):1479-86. doi: 10.1158/1078-0432.CCR-05-1519.

引用本文的文献

1
Expression of the RPSA-Containing and 67EBP Laminin Receptors in Relation to the Debatable Nature of the 67 kDa Laminin Receptor 67LR in Colorectal Cancer.含RPSA的层粘连蛋白受体和67EBP层粘连蛋白受体在结直肠癌中与67kDa层粘连蛋白受体67LR的争议性质的关系
Int J Mol Sci. 2025 Mar 12;26(6):2564. doi: 10.3390/ijms26062564.
2
Epigallocatechin Gallate (EGCG): Pharmacological Properties, Biological Activities and Therapeutic Potential.表没食子儿茶素没食子酸酯(EGCG):药理特性、生物活性及治疗潜力
Molecules. 2025 Feb 1;30(3):654. doi: 10.3390/molecules30030654.
3
The fusion gene LRP1-SNRNP25 drives invasion and migration by activating the pJNK/37LRP/MMP2 signaling pathway in osteosarcoma.
融合基因LRP1-SNRNP25通过激活骨肉瘤中的pJNK/37LRP/MMP2信号通路来驱动侵袭和迁移。
Cell Death Discov. 2024 Apr 27;10(1):198. doi: 10.1038/s41420-024-01962-z.
4
Reconsideration of the laminin receptor 67LR in colorectal cancer cells.重新考虑结直肠癌细胞中的层粘连蛋白受体 67LR。
Biomol Biomed. 2024 Sep 6;24(5):1117-1132. doi: 10.17305/bb.2024.10323.
5
Channeling the Natural Properties of Sindbis Alphavirus for Targeted Tumor Therapy.利用辛德毕斯甲病毒的天然特性进行靶向肿瘤治疗。
Int J Mol Sci. 2023 Oct 6;24(19):14948. doi: 10.3390/ijms241914948.
6
Treatment with YIGSR peptide ameliorates mouse tail lymphedema by 67 kDa laminin receptor (67LR)-dependent cell-cell adhesion.YIGSR肽治疗通过依赖67 kDa层粘连蛋白受体(67LR)的细胞间黏附改善小鼠尾部淋巴水肿。
Biochem Biophys Rep. 2023 Jul 20;35:101514. doi: 10.1016/j.bbrep.2023.101514. eCollection 2023 Sep.
7
Natural-product-based fluorescent probes: recent advances and applications.基于天然产物的荧光探针:最新进展与应用
RSC Med Chem. 2022 Dec 20;14(3):412-432. doi: 10.1039/d2md00376g. eCollection 2023 Mar 22.
8
Src Mediates Epigallocatechin-3--Gallate-Elicited Acid Sphingomyelinase Activation.Src 介导表没食子儿茶素没食子酸酯诱导的酸性鞘磷脂酶激活。
Molecules. 2020 Nov 23;25(22):5481. doi: 10.3390/molecules25225481.
9
Targeting the Extra-Cellular Matrix-Tumor Cell Crosstalk for Anti-Cancer Therapy: Emerging Alternatives to Integrin Inhibitors.靶向细胞外基质-肿瘤细胞串扰进行抗癌治疗:整合素抑制剂的新兴替代方案
Front Oncol. 2020 Jul 22;10:1231. doi: 10.3389/fonc.2020.01231. eCollection 2020.
10
Changes in the in vitro activity of platinum drugs when administered in two aliquots.分两次给药时铂类药物体外活性的变化。
BMC Cancer. 2016 Aug 26;16(1):688. doi: 10.1186/s12885-016-2731-1.